COMING SOON — SMRT Technology
Expression Analysis is the first U.S. commercial service provider of Pacific Biosciences technology and will receive one of the first commercially released instruments.
Anticipated to launch during the fourth quarter of 2010, the SMRT Technology platform will soon enable us to better serve the requirements of the pharmaceutical and biotechnology industries, specifically as it relates to oncology and infectious disease research.
The longer read lengths will allow sequencing of complex regions of the genome never before possible and provide a more thorough understanding of structural genetic variations.
Expression Analysis is dedicated to helping you push the limits of your biological research and accelerating discoveries with this genuine breakthrough in DNA sequencing.
To keep up-to-date on this product launch, or to discuss a potential project with Expression Analysis, please Click here.